DURECT Corporation Depreciation & Amortization 2011-2026 | DRRX

Annual Depreciation & Amortization DURECT Corporation

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
31 K	119 K	288 K	297 K	291 K	254 K	437 K	416 K	425 K	601 K	558 K	964 K	1.18 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.18 M	31 K	451 K

Quarterly Depreciation & Amortization DURECT Corporation

2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	69 K	-	-	51 K	-	-	44 K	-	109 K	-	34 K	-	92 K	-	30 K	-	219 K	139 K	62 K	-	224 K	153 K	82 K	-	162 K	221 K	108 K	-	333 K	224 K	112 K	-	309 K	206 K	101 K	-	342 K	260 K	144 K	-	462 K	310 K	155 K	-	381 K	512 K	258 K	-	688 K	429 K	205 K	-	735 K	519 K	284 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
735 K	30 K	237 K

Depreciation & Amortization of other stocks in the Drug manufacturers industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Zynerba Pharmaceuticals ZYNE	219 K	-	-	$ 55.5 M	USA
Alimera Sciences ALIM	8.75 M	-	-	$ 142 M	USA
Adamis Pharmaceuticals Corporation ADMP	1.48 M	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	6.4 M	-	-	$ 754 M	USA
Canopy Growth Corporation CGC	21.5 M	$ 1.2	0.42 %	$ 129 M	Canada
AcelRx Pharmaceuticals ACRX	311 K	-	7.5 %	$ 6.35 M	USA
Agile Therapeutics AGRX	102 K	-	10.11 %	$ 58.2 M	USA
Catalent CTLT	489 M	-	-	$ 11.5 B	USA
Eagle Pharmaceuticals EGRX	646 K	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	306 M	-	-	$ 28.9 M	Irlanda
Emergent BioSolutions EBS	125 M	$ 12.84	2.8 %	$ 657 M	USA
Athenex ATNX	4.47 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	2.68 M	$ 21.5	-0.12 %	$ 2.05 B	France
Evolus EOLS	5.3 M	$ 6.03	-10.27 %	$ 374 M	USA
Harrow Health HROW	1.06 M	$ 54.06	8.3 %	$ 1.76 B	USA
Jupiter Wellness JUPW	429 K	-	-	$ 33.6 M	USA
China Pharma Holdings CPHI	2.62 M	$ 1.23	1.65 %	$ 21.5 M	China
Bausch Health Companies BHC	1.26 B	$ 7.51	4.16 %	$ 2.74 B	Canada
Lannett Company LCI	34.3 M	-	1.15 %	$ 7.11 M	USA
Neoleukin Therapeutics NLTX	3.26 M	-	-	$ 193 M	Canada
Cumberland Pharmaceuticals CPIX	4.9 M	$ 3.95	-0.77 %	$ 55.5 M	USA
Organogenesis Holdings ORGO	13.6 M	$ 4.36	-5.93 %	$ 574 M	USA
Pacira BioSciences PCRX	78.8 M	$ 25.21	3.07 %	$ 1.17 B	USA
Sonoma Pharmaceuticals SNOA	138 K	$ 3.73	2.46 %	$ 4.63 M	USA
Rockwell Medical RMTI	1.44 M	$ 0.98	13.92 %	$ 22.9 M	USA
PetIQ PETQ	44.5 M	-	1.64 %	$ 400 M	USA
Perrigo Company plc PRGO	326 M	$ 14.36	3.42 %	$ 1.97 B	USA
ProPhase Labs PRPH	4.72 M	-	-	$ 5.07 M	USA
Veru VERU	268 K	$ 2.28	0.58 %	$ 308 M	USA
Radius Health RDUS	1.16 M	-	-	$ 1.42 B	USA
Recro Pharma REPH	8.22 M	-	-4.76 %	$ 65.3 M	USA
cbdMD YCBD	452 K	$ 1.11	-4.31 %	$ 4.79 M	USA
Relmada Therapeutics RLMD	1.26 K	$ 4.11	-6.06 %	$ 124 M	USA
OptiNose OPTN	402 K	-	-	$ 1.08 B	USA
Assertio Holdings ASRT	28.2 M	$ 9.62	5.25 %	$ 683 M	USA
PLx Pharma PLXP	116 K	-	-27.8 %	$ 2.56 M	USA
Solid Biosciences SLDB	2.46 M	$ 5.33	-2.14 %	$ 218 M	USA
SCYNEXIS SCYX	580 K	$ 0.64	-0.03 %	$ 30.6 M	USA
Tricida TCDA	442 K	-	-	$ 3.25 M	USA
Tilray TLRY	35.7 M	$ 9.43	-3.03 %	$ 5.83 B	Canada
TherapeuticsMD TXMD	922 K	$ 1.79	8.78 %	$ 18.7 M	USA
Zomedica Corp. ZOM	830 K	-	-0.21 %	$ 98 M	USA